Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Effect of a Digital Storytelling Program on Fall Among Community-Dwelling Older Adults

29 augustus 2026 bijgewerkt door: Gizem Deniz Büyüksoy, Kirsehir Ahi Evran Universitesi

The Effect of a Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy Among Community-Dwelling Older Adults

This study aims to examine fall behaviors, fear of falling, and self-efficacy levels in older adults living at home through a digital storytelling program based on Pender's Health Promotion Model, and to evaluate the effect of this program on these variables. Research hypotheses:

H1.1: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the number of falls among the elderly.

H1.2: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the risk of falls among the elderly.

H1.3: The Digital Storytelling Program based on Pender's Health Promotion Model reduces the fear of falling among the elderly.

H1.4: The Digital Storytelling Program based on Pender's Health Promotion Model affects the total score of the Falling Behaviors Scale for the Elderly (FBS) among the elderly.

The general population of the study consisted of 80 individuals aged 65 and over registered at family health centers in Avanos district of Nevşehir province. The sample of the study was calculated as 80 people in the analysis performed using the "G. Power-3.1" program with 95% power, 0.05 margin of error and 0.82 effect size. The effect of safe movement and walking program on reducing fear of falling in elderly individuals living in nursing homes. In the study, 40 people were assigned to each group using stratified randomization method.

Inclusion criteria:

Literate, Living at home, 65 years and older, Having internet access, Able to use communication tools such as computers, tablets or smartphones, Able to communicate verbally and visually, Not having physical conditions or diseases that would prevent exercise (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease-aortic stenosis, angina, severe musculoskeletal disease, knee and hip replacement in the last 6 months). (being bedridden),

Agreeing to participate in the study. Exclusion criteria:

Bedridden, Visually impaired, Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24).

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Werkelijk)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Kırşehir
      • Kırşehir, Kırşehir, Turkije (Türkiye), 40000
        • Kırsehir Ahi Evran University

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • Participants must be literate,
  • Live at home,
  • 65 years of age or older,
  • Have internet access,
  • Able to use communication tools such as computers, tablets or smartphones,
  • Able to communicate verbally and visually,
  • Not have any physical condition or illness that would prevent them from exercising (Stroke, Parkinson's, uncontrolled arrhythmia, serious heart disease - aortic stenosis, angina, severe musculoskeletal disease, having had knee or hip replacement surgery in the last 6 months),
  • Agree to participate in the study.

Exclusion Criteria:

  • Bedridden,
  • Visually impaired,
  • Moderate to severe cognitive impairment (Mini Mental State Test - MMD <24)

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Geen tussenkomst: Controlegroep
Actieve vergelijker: Intervention Group
'Digital Storytelling Program Based on Pender's Health Promotion Model on Fall Behaviors, Fear of Falling, and Self-Efficacy'

Pre-intervention: Elderly individuals meeting the inclusion and exclusion criteria will be administered an introductory information form, the Fear of Falls Scale, and the Fall Behaviors Scale for the Elderly.

Intervention implementation: Elderly individuals in the experimental group will be shown digital stories prepared within the framework of Pender's Health Promotion Model-Based Digital Storytelling Program, focusing on Individual Characteristics and Experiences, Behavior-Specific Concepts and Effects, and Behavioral Outcomes. Post-intervention: Immediately after the six-week intervention and three months after its completion, the Fear of Falls Scale and the Fall Behaviors Scale for the Elderly will be collected through face-to-face interviews with individuals.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Fear of Falling Scale
Tijdsspanne: From enrollment to the end of treatment at 12 weeks.
The "Fear of Falling Scale" is used to assess a person's fear of falling while performing daily activities and developed by Tinetti et al. (1990). The scale, consisting of 10 items, has a Cronbach's alpha coefficient of 0.71 in the original study. The Turkish version, validated and proven reliable by Erdem and Emel (2004). The scale items inquire whether individuals experience fear of falling while performing activities such as "bathing, reaching into a cupboard to get an item, walking in the garden, answering the door or phone, sitting down and standing up from a chair, dressing and undressing, getting in and out of bed, doing chores in their room, and simple shopping." For each question, individuals receive "1 point for Yes" if they experience fear of falling and "0 points for No" if they do not. An increase in the average fear of falling score indicates an increased fear of falling while performing daily life activities.
From enrollment to the end of treatment at 12 weeks.
Self-Efficacy/Competence Scale
Tijdsspanne: From enrollment to the end of treatment at 12 weeks
It was developed and revised by Sherer et al. (63) in 1982. Its reliability and validity in Turkish was established by Gözüm and Aksayan (9) in 1999. The Cronbach Alpha value is 0.81, and the test-retest reliability was found to be 0.92. The scale consists of 23 items and four sub-factors (behavior initiation, behavior completion, behavior maintenance, and overcoming obstacles). A minimum score of 23 and a maximum score of 115 are obtained from the scale. A high total score indicates a high perception of self-efficacy/competence. It is a 5-point Likert-type scale. It consists of options ranging from "Does not describe me at all" (1) to "Describes me very well" (5). However, items 2, 4, 5, 6, 7, 10, 11, 12, 14, 16, 17, 18, 20, and 22 are scored in the opposite direction.
From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly
Tijdsspanne: From enrollment to the end of treatment at 12 weeks
Fall Behavior Scale for the Elderly: Developed by Clemson et al. (2003), this scale consists of 30 items and 10 sub-dimensions. Based on self-report, the scale aims to identify the behaviors and awareness that older adults exhibit to protect themselves from potential falls. The items in the scale inquire about activities related to home life, lighting and vision, shoe use, outdoor activities, and daily life. Each item is scored from 1 to 4 on a 4-point Likert scale. "Never" is worth 1 point, while the others are worth 2 points each for "occasionally," 3 points for "usually," and 4 points for "always." The lowest and highest possible scores for the total scale and its subscales range from 1 to 4. Higher scores indicate safe/protective behaviors related to falls, while lower scores indicate risky behaviors. The sub-dimensions of the scale are as follows: The scale consists of the following items: Cognitive Adaptation (6 items), Mobility (5 items), Avoidance (5 items), Awareness (4 items
From enrollment to the end of treatment at 12 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 april 2026

Primaire voltooiing (Werkelijk)

30 augustus 2026

Studie voltooiing (Werkelijk)

30 augustus 2026

Studieregistratiedata

Eerst ingediend

22 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

1 juni 2026

Eerst geplaatst (Werkelijk)

5 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 september 2026

Laatste update ingediend die voldeed aan QC-criteria

29 augustus 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2025.12.19

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

IPD delen Ondersteunend informatietype

  • ANALYTIC_CODE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren